Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.
September 24, 2015
Potential Alzheimer’s drug gets funding for clinical testing
What could be one of the first treatments to delay or prevent Alzheimer’s disease received a big boost from the National Institute on Aging, which is putting up $7.5 million to help fund the next round of trials for the drug being developed by a Baltimore start-up and the Johns Hopkins University.
